Salesforce
CRM
$196.21
-2.56%
Salesforce, Inc. is a leading provider of enterprise cloud computing solutions, offering customer relationship management (CRM) technology and a comprehensive Customer 360 platform that integrates sales, service, marketing, and commerce applications. As a dominant player in the CRM market, Salesforce differentiates itself through its extensive ecosystem, AI-driven innovations like Agentforce, and strategic acquisitions such as MuleSoft and Tableau. The current investor narrative centers on Salesforce's AI transformation, highlighted by a recent $1.6 billion federal AI contract win, which validates Agentforce demand, while the stock faces pressure from broader tech sector volatility and concerns about enterprise spending shifts. Investors are debating whether Salesforce's AI investments can sustain growth and justify its valuation after a significant drawdown from 52-week highs.…
CRM
Salesforce
$196.21
Related headlines
Investment Opinion: Should I buy CRM Today?
We rate Salesforce as a Buy, driven by its accelerating revenue growth, strong AI momentum, and attractive forward valuation. The consensus 'buy' rating and average target of $241.72 imply 29.4% upside, supporting our positive stance. Key data points include 13.27% YoY revenue growth, a forward PE of 12.04x (45% below industry), a gross margin of 77.7%, and $14.66 billion in TTM free cash flow. Risks include macro headwinds and competitive pressures, but the AI contract win and analyst sentiment provide a favorable risk/reward. This Buy would be downgraded if revenue growth falls below 10% or if the forward PE expands above 20x, while an upgrade would require sustained growth above 15% and margin expansion. Overall, the stock appears undervalued relative to its growth prospects and historical valuation.
Sign up to view all
CRM 12-Month Price Forecast
The AI assessment is bullish with medium confidence. Salesforce's AI strategy is gaining traction, as evidenced by the federal contract and accelerating revenue growth. The forward valuation is attractive, but macro headwinds and competitive pressures introduce uncertainty. If the company can sustain growth above 12% and demonstrate AI-driven margin expansion, the stock could re-rate higher. Conversely, any signs of AI monetization delays or growth deceleration would warrant a downgrade to neutral.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $242.43 and implied upside of +23.6% versus the current price.
Average Target
$242.43
0 analysts
Implied Upside
+23.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$160 - $475
Analyst target range
Salesforce is covered by 53 analysts, with a consensus recommendation of 'buy' and a mean recommendation score of 1.66 (where 1 is strong buy and 5 is sell). The average target price is $241.72, implying a 29.4% upside from the current price of $186.77. The distribution of ratings is bullish, with recent actions including upgrades from Guggenheim (Neutral to Buy) and Keybanc (Overweight to Sector Weight), indicating mixed but generally positive sentiment. The target price range spans from a low of $160.00 to a high of $475.00, representing a wide spread of 197% between the low and high, which signals high uncertainty about the company's future performance. The high target of $475 assumes significant AI-driven growth and multiple expansion, while the low target of $160 prices in potential margin compression and competitive pressures. Recent institutional actions show a mix of upgrades and downgrades, with Evercore ISI reiterating Outperform and Keybanc downgrading to Sector Weight, reflecting the debate over Salesforce's AI monetization and spending environment.
Bulls vs Bears: CRM Investment Factors
Salesforce presents a mixed picture: strong fundamentals with accelerating revenue growth, a validated AI strategy, and a compelling forward valuation, but offset by significant underperformance, macro headwinds, and a high trailing PE. The bull case rests on the belief that AI-driven growth will justify the forward discount, while the bear case hinges on the risk that enterprise spending shifts away from software and growth decelerates. Currently, the evidence slightly favors the bull case given the strong analyst consensus and the AI contract win, but the stock's poor price action and macro risks warrant caution. The key tension is whether Salesforce can translate its AI momentum into sustained revenue acceleration and margin expansion, which would validate the forward PE and drive the stock higher.
Bullish
- AI Contract Win Validates Agentforce: Salesforce secured a $1.6 billion federal AI contract, signaling strong demand for its Agentforce platform and moving AI from pilot to procurement. This validates the company's AI strategy and could drive significant revenue growth.
- Revenue Growth Accelerating: Q1 FY2027 revenue grew 13.27% YoY to $11.13 billion, up from 8.5% growth in the prior year quarter. This acceleration indicates improving demand and successful execution of its AI and cloud strategy.
- Forward PE at 45% Discount to Industry: The forward PE of 12.04x is 45% below the industry average of 22x, suggesting the market is pricing in substantial earnings growth. This implies significant upside if the company meets earnings expectations.
- Strong Analyst Consensus and Upside: With a consensus 'buy' rating and an average target price of $241.72, analysts see 29.4% upside from the current price. The mean recommendation score of 1.66 indicates strong bullish sentiment.
Bearish
- Significant Underperformance vs. S&P 500: CRM stock is down 25.04% over the past year, while the S&P 500 gained 21.46%. This underperformance reflects investor concerns about growth sustainability and competitive pressures.
- High Valuation Premium on Trailing PE: The trailing PE of 27.04x is 23% above the industry average of 22x, indicating the market still pays a premium for Salesforce's growth. If growth decelerates, the stock could face de-rating.
- Macro Headwinds from Inflation and Spending Shifts: Recent inflation prints above 4% are capping equity multiples, and IBM's guidance suggests enterprise spending is shifting from software to hardware. This could pressure Salesforce's revenue growth and margins.
- Wide Analyst Target Range Signals Uncertainty: The analyst target range spans from $160 to $475, a 197% spread, indicating high uncertainty about future performance. This wide dispersion suggests significant risk in both directions.
CRM Technical Analysis
Salesforce's stock has been in a pronounced downtrend over the past year, with a 1-year price change of -25.04%, significantly underperforming the S&P 500's +21.46% gain. The current price of $186.77 sits at 30.4% of its 52-week range (between $146.32 low and $269.11 high), indicating the stock is trading near the lower end of its range, which could signal a value opportunity or a falling knife depending on fundamental catalysts. The stock has experienced a maximum drawdown of -45.14% from its highs, reflecting the severity of the selloff.
Beta
1.15
1.15x market volatility
Max Drawdown
-44.5%
Largest decline past year
52-Week Range
$146-$269
Price range past year
Annual Return
-15.9%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | +17.5% | +2.9% |
| 3m | +13.1% | +5.0% |
| 6m | +3.4% | +13.9% |
| 1y | -15.9% | +20.4% |
| ytd | -22.6% | +13.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Salesforce's revenue growth remains solid, with the most recent quarter (Q1 FY2027, ending April 30, 2026) reporting revenue of $11.13 billion, a 13.27% year-over-year increase. This growth is consistent with the prior quarter's $11.20 billion (Q4 FY2026) and represents an acceleration from the 8.5% growth seen in Q1 FY2026, indicating a stable growth trajectory. The company's subscription and support segment, which generated $10.59 billion, is the primary growth driver, while professional services contributed $540 million. The revenue growth is supported by strong demand for AI-powered solutions like Agentforce, as evidenced by the recent $1.6 billion federal contract.
Quarterly Revenue
$11.1B
2026-04
Revenue YoY Growth
+13.3%
YoY Comparison
Gross Margin
76.9%
Latest Quarter
Free Cash Flow
$14.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
Given Salesforce's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 27.04x, while the forward PE is 12.04x, implying a significant discount to future earnings, which suggests the market expects substantial earnings growth. The gap between trailing and forward PE indicates that analysts anticipate a sharp increase in EPS, likely driven by AI-driven efficiency gains and margin expansion. Compared to the industry average PE of 22x (from valuation data), Salesforce's trailing PE of 27.04x represents a 23% premium, but the forward PE of 12.04x is at a 45% discount, suggesting the market is pricing in superior future growth. Historically, Salesforce's PE has ranged from 18.16x to 670x over the past five years, with the current trailing PE near the lower end, indicating the stock is trading at a historically attractive valuation relative to its own earnings power.
PE
27.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~247x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a debt-to-equity ratio of 0.29, which is manageable, but the current ratio of 0.76 indicates potential liquidity concerns. The company's reliance on continued growth to justify its valuation is a risk, as any deceleration could trigger multiple compression. Additionally, the high payout ratio of 21.3% and dividend yield of 0.79% suggest limited income support, and the stock's beta of 1.15 implies higher volatility than the market.
FAQ
The key risks include: 1) Financial risk: The current ratio of 0.76 suggests potential liquidity issues, though debt-to-equity is low at 0.29. 2) Competitive risk: Intense competition from Microsoft and others could pressure market share and pricing. 3) Macro risk: High inflation and shifts in enterprise spending away from software, as seen in IBM's guidance, could hurt revenue growth. 4) Company-specific risk: The success of AI initiatives like Agentforce is uncertain; if monetization disappoints, the stock could suffer. The stock's beta of 1.15 also implies higher volatility than the market.
The 12-month forecast is bullish, with a base case probability of 50% targeting $220-$250, aligning with the analyst average of $241.72. The bull case (30% probability) targets $250-$300, driven by strong AI adoption, while the bear case (20% probability) targets $150-$170, near the 52-week low, if growth decelerates. The most likely scenario is the base case, assuming revenue growth remains in the low-to-mid teens and AI contributions gradually increase. Analysts have a consensus 'buy' rating, supporting a positive outlook.
Salesforce's valuation is mixed. The trailing PE of 27.04x is 23% above the industry average of 22x, suggesting a premium. However, the forward PE of 12.04x is 45% below the industry, implying the market expects significant earnings growth. Historically, the stock has traded at PE ratios ranging from 18x to 670x, and the current trailing PE is near the lower end, indicating it is relatively cheap by its own standards. The market is pricing in substantial EPS growth, likely driven by AI and margin expansion. If the company delivers on these expectations, the stock is undervalued; if not, it could be overvalued.
Salesforce appears to be a good buy for investors with a long-term horizon and a tolerance for volatility. The stock is trading at a forward PE of 12.04x, a 45% discount to the industry average, and analysts see 29.4% upside to the average target of $241.72. The recent $1.6 billion federal AI contract win validates the AI strategy and could drive growth. However, the stock has underperformed the market over the past year, and macro headwinds could pressure near-term performance. For investors who believe in the AI transformation, the risk/reward is attractive, but it's essential to monitor execution and spending trends.
Salesforce is better suited for long-term investment due to its growth stage and volatility (beta 1.15). The company is investing heavily in AI, which may take time to yield results, and the stock has shown significant price swings. Short-term trading is possible given the recent rebound, but the high uncertainty and wide analyst target range make it risky. For long-term investors, a holding period of at least 3-5 years is recommended to allow the AI strategy to mature and earnings to catch up with the valuation. The dividend yield is low at 0.79%, so income is not a primary reason to hold.